Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2017 1
2018 1
2019 2
2020 16
2021 11
2022 9
2023 7
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Proper JL, Siegel LK, Klatt NR, Odde DJ, Luke DG, Anderson B, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Biros M, Sherwood NE, Thompson JL, Boulware DR, Murray TA; COVID-OUT Trial Team. Bramante CT, et al. Among authors: ingraham ne. N Engl J Med. 2022 Aug 18;387(7):599-610. doi: 10.1056/NEJMoa2201662. N Engl J Med. 2022. PMID: 36070710 Free PMC article. Clinical Trial.
Immunomodulation in COVID-19.
Ingraham NE, Lotfi-Emran S, Thielen BK, Techar K, Morris RS, Holtan SG, Dudley RA, Tignanelli CJ. Ingraham NE, et al. Lancet Respir Med. 2020 Jun;8(6):544-546. doi: 10.1016/S2213-2600(20)30226-5. Epub 2020 May 4. Lancet Respir Med. 2020. PMID: 32380023 Free PMC article. No abstract available.
Antihypertensive drugs and risk of COVID-19?
Tignanelli CJ, Ingraham NE, Sparks MA, Reilkoff R, Bezdicek T, Benson B, Schacker T, Chipman JG, Puskarich MA. Tignanelli CJ, et al. Among authors: ingraham ne. Lancet Respir Med. 2020 May;8(5):e30-e31. doi: 10.1016/S2213-2600(20)30153-3. Epub 2020 Mar 26. Lancet Respir Med. 2020. PMID: 32222166 Free PMC article. No abstract available.
Deriving a definition of chronic critical illness: ICU stay of 10 days.
Morris R, Al Tannir AH, Chipman J, Charles A, Ingraham NE, Kalinoski M, Bolden L, Siegel L, Tignanelli CJ. Morris R, et al. Among authors: ingraham ne. Am J Surg. 2024 Nov;237:115767. doi: 10.1016/j.amjsurg.2024.05.008. Epub 2024 May 18. Am J Surg. 2024. PMID: 38782686 No abstract available.
mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses.
Karam BS, Morris RS, Bramante CT, Puskarich M, Zolfaghari EJ, Lotfi-Emran S, Ingraham NE, Charles A, Odde DJ, Tignanelli CJ. Karam BS, et al. Among authors: ingraham ne. J Med Virol. 2021 Apr;93(4):1843-1846. doi: 10.1002/jmv.26728. Epub 2020 Dec 17. J Med Virol. 2021. PMID: 33314219 Free PMC article. Review.
Discordant Cardiopulmonary Resuscitation and Code Status at Death.
Robbins AJ, Ingraham NE, Sheka AC, Pendleton KM, Morris R, Rix A, Vakayil V, Chipman JG, Charles A, Tignanelli CJ. Robbins AJ, et al. Among authors: ingraham ne. J Pain Symptom Manage. 2021 Apr;61(4):770-780.e1. doi: 10.1016/j.jpainsymman.2020.09.015. Epub 2020 Sep 17. J Pain Symptom Manage. 2021. PMID: 32949762 Free PMC article.
Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
Ingraham NE, Boulware D, Sparks MA, Schacker T, Benson B, Sparks JA, Murray T, Connett J, Chipman JG, Charles A, Tignanelli CJ. Ingraham NE, et al. Crit Care. 2020 Apr 28;24(1):182. doi: 10.1186/s13054-020-02894-7. Crit Care. 2020. PMID: 32345336 Free PMC article. No abstract available.
47 results